256 related articles for article (PubMed ID: 31600211)
21. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
[TBL] [Abstract][Full Text] [Related]
22. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
Zhu M; Jia N; Huang F; Liu X; Zhao Y; Tao X; Jiang W; Li Q; Feng W
BMC Cancer; 2017 Oct; 17(1):696. PubMed ID: 29061125
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma.
Akar S; Çelik ZE; Fındık S; İlhan TT; Ercan F; Çelik Ç
Int J Clin Oncol; 2020 Jan; 25(1):195-202. PubMed ID: 31452018
[TBL] [Abstract][Full Text] [Related]
24. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
[TBL] [Abstract][Full Text] [Related]
25. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
26. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Clinical Significance of Lymphovascular Space Invasion in Stage IA Endometrial Cancer.
Okugawa K; Yahata H; Hachisuga K; Tomonobe H; Yasutake N; Kodama K; Kenjo H; Yagi H; Ohgami T; Yasunaga M; Onoyama I; Asanoma K; Hori E; Ohishi Y; Oda Y; Kato K
Oncology; 2022; 100(4):195-202. PubMed ID: 34915516
[TBL] [Abstract][Full Text] [Related]
28. Pathological findings in early-stage endometrial cancer.
Zehavi S; Schneider D; Bukovsky I; Halperin R
Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
[TBL] [Abstract][Full Text] [Related]
29. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
[TBL] [Abstract][Full Text] [Related]
30. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
[TBL] [Abstract][Full Text] [Related]
31. Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters.
Kapucuoglu N; Bulbul D; Tulunay G; Temel MA
Int J Gynecol Cancer; 2008; 18(4):790-6. PubMed ID: 17892460
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of immunohistochemically detected lymphatic and vascular invasions in clinically staged endometrioid endometrial cancer.
Alexander-Sefre F; Nibbs R; Rafferty T; Ayhan A; Singh N; Jacobs I
Int J Gynecol Cancer; 2009 Aug; 19(6):1074-9. PubMed ID: 19820371
[TBL] [Abstract][Full Text] [Related]
34. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
[TBL] [Abstract][Full Text] [Related]
35. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
36. Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
Backes FJ; Haag J; Cosgrove CM; Suarez A; Cohn DE; Goodfellow PJ
Cancer; 2019 Feb; 125(3):398-405. PubMed ID: 30561762
[TBL] [Abstract][Full Text] [Related]
37. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.
Desrosiers L; Fadare O; Xiao ZF; Dresser K; Wang SA
Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471
[TBL] [Abstract][Full Text] [Related]
38. Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study.
Ørtoft G; Lausten-Thomsen L; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2019 Sep; 30(5):e84. PubMed ID: 31328462
[TBL] [Abstract][Full Text] [Related]
39. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S
Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]